Your browser doesn't support javascript.
loading
The uracil-DNA glycosylase UNG protects the fitness of normal and cancer B cells expressing AID.
Safavi, Shiva; Larouche, Ariane; Zahn, Astrid; Patenaude, Anne-Marie; Domanska, Diana; Dionne, Kiersten; Rognes, Torbjørn; Dingler, Felix; Kang, Seong-Kwi; Liu, Yan; Johnson, Nathalie; Hébert, Josée; Verdun, Ramiro E; Rada, Cristina A; Vega, Francisco; Nilsen, Hilde; Di Noia, Javier M.
Afiliação
  • Safavi S; Institut de Recherches Cliniques de Montréal, 110 Av des Pins Ouest, Montréal, QC H2W 1R7, Canada.
  • Larouche A; Institut de Recherches Cliniques de Montréal, 110 Av des Pins Ouest, Montréal, QC H2W 1R7, Canada.
  • Zahn A; Institut de Recherches Cliniques de Montréal, 110 Av des Pins Ouest, Montréal, QC H2W 1R7, Canada.
  • Patenaude AM; Institut de Recherches Cliniques de Montréal, 110 Av des Pins Ouest, Montréal, QC H2W 1R7, Canada.
  • Domanska D; Department of Informatics, University of Oslo, PO Box 1080, Blindern, 0316 Oslo, Norway.
  • Dionne K; Institut de Recherches Cliniques de Montréal, 110 Av des Pins Ouest, Montréal, QC H2W 1R7, Canada.
  • Rognes T; Department of Informatics, University of Oslo, PO Box 1080, Blindern, 0316 Oslo, Norway.
  • Dingler F; MRC Laboratory of Molecular Biology, Cambridge CB2 0QH, UK.
  • Kang SK; ITR Laboratories Canada, Inc., 19601 Clark Graham Ave, Baie-D'Urfe, QC H9X 3T1, Canada.
  • Liu Y; Section for Clinical Molecular Biology, Akershus University Hospital, PO 1000, 1478 Lørenskog, Norway.
  • Johnson N; Division of Experimental Medicine, Department of Medicine, McGill University, Montréal, QC H4A 3J1, Canada.
  • Hébert J; Department of Medicine, Université de Montréal, C.P. 6128, Montreal, QC H3C 3J7, Canada.
  • Verdun RE; Division of Hematology, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL 33136, USA.
  • Rada CA; MRC Laboratory of Molecular Biology, Cambridge CB2 0QH, UK.
  • Vega F; Division of Hematology, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL 33136, USA.
  • Nilsen H; Section for Clinical Molecular Biology, Akershus University Hospital, PO 1000, 1478 Lørenskog, Norway.
  • Di Noia JM; Institut de Recherches Cliniques de Montréal, 110 Av des Pins Ouest, Montréal, QC H2W 1R7, Canada.
NAR Cancer ; 2(3): zcaa019, 2020 Sep.
Article em En | MEDLINE | ID: mdl-33554121
ABSTRACT
In B lymphocytes, the uracil N-glycosylase (UNG) excises genomic uracils made by activation-induced deaminase (AID), thus underpinning antibody gene diversification and oncogenic chromosomal translocations, but also initiating faithful DNA repair. Ung-/- mice develop B-cell lymphoma (BCL). However, since UNG has anti- and pro-oncogenic activities, its tumor suppressor relevance is unclear. Moreover, how the constant DNA damage and repair caused by the AID and UNG interplay affects B-cell fitness and thereby the dynamics of cell populations in vivo is unknown. Here, we show that UNG specifically protects the fitness of germinal center B cells, which express AID, and not of any other B-cell subset, coincident with AID-induced telomere damage activating p53-dependent checkpoints. Consistent with AID expression being detrimental in UNG-deficient B cells, Ung-/- mice develop BCL originating from activated B cells but lose AID expression in the established tumor. Accordingly, we find that UNG is rarely lost in human BCL. The fitness preservation activity of UNG contingent to AID expression was confirmed in a B-cell leukemia model. Hence, UNG, typically considered a tumor suppressor, acquires tumor-enabling activity in cancer cell populations that express AID by protecting cell fitness.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article